Atalaya Capital Management’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-150,000
| Closed | -$1.55M | – | 151 |
|
|
2023
Q2 | $1.55M | Hold |
150,000
| – | – | 0.75% | 26 |
|
|
2023
Q1 | $1.52M | Hold |
150,000
| – | – | 0.48% | 48 |
|
|
2022
Q4 | $1.49M | Hold |
150,000
| – | – | 0.27% | 79 |
|
|
2022
Q3 | $1.46M | Hold |
150,000
| – | – | 0.2% | 112 |
|
|
2022
Q2 | $1.46M | Hold |
150,000
| – | – | 0.17% | 137 |
|
|
2022
Q1 | $1.46M | Hold |
150,000
| – | – | 0.15% | 147 |
|
|
2021
Q4 | $1.45M | Hold |
150,000
| – | – | 0.14% | 145 |
|
|
2021
Q3 | $1.45M | Buy |
+150,000
| New | +$1.45M | 0.22% | 95 |
|